Apogem Capital LLC Charles River Laboratories International, Inc. Transaction History

Apogem Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $42,873 - $58,876	235 Added 11.01%	2,370 $466,000
Q2 2022 Aug 15, 2022	SELL	$204.13 - $302.4 $39,601 - $58,665	-194 Reduced 8.33%	2,135 $457,000
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $297,669 - $421,858	1,165 Added 100.09%	2,329 $661,000
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $409,006 - $522,263	1,164 New	1,164 $439,000

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Apogem Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Apogem Capital LLC with notifications on news.